CTS5 Online Test for determining if only five years of hormone therapy is okay instead of ten

Hi @primek that’s very interesting.  Am I reading this right — that endocrine therapy only has an impact on local recurrence and other breast recurrence, but that it does zip for reducing the risk of distant mestastes?  That seems like an important point to just elide over in all the material about the benefits of endocrine therapy!  

And the second one... so whether you take an aromatise inhibitor treatment for a longer period or not, you are just as likely to die, but perhaps without a recurrence in either breast?  

The first thing kind of explains the second one, I guess.   Urgh.